Literature DB >> 10028063

Clinical experience and choice of drug therapy for human immunodeficiency virus disease.

C L Brosgart1, T F Mitchell, R L Coleman, T Dyner, K E Stephenson, D I Abrams.   

Abstract

To determine if providers experienced in the management of human immunodeficiency virus (HIV) disease preferred different treatment regimens than providers with less experience, we analyzed data from a national survey of primary care providers' preferred regimens for the management of 30 HIV-related medical conditions. We mailed questionnaires to 999 correct addresses of providers in > 20 cities in the United States in May 1996. We received 524 responses (response rate, 52%). We found a statistically significant association between the number of HIV-infected patients cared for by the provider and the likelihood that the provider would report prescribing highly active antiretroviral therapy and multidrug combinations for treatment of opportunistic infections. Providers with few HIV-infected patients were substantially less likely to report using new therapeutic regimens or new diagnostic tools. We concluded that the preferred regimens of experienced providers are more likely to be consistent with the latest information on treatment for HIV disease than are those of less experienced providers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028063     DOI: 10.1086/515081

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Care rendered by general internists, committed to the care of HIV-infected patients, compares favorably with that given by infectious disease physicians.

Authors:  David W Lehman; Joel Witter; Martina Schulte; Josh Blum; Terence Shea; Philip S Mehler
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

2.  Quality primary care for HIV/AIDS: how much HIV/AIDS experience is enough?

Authors:  Valerie E Stone
Journal:  J Gen Intern Med       Date:  2003-02       Impact factor: 5.128

3.  Qualifications, Demographics, Satisfaction, and Future Capacity of the HIV Care Provider Workforce in the United States, 2013-2014.

Authors:  John Weiser; Linda Beer; Brady T West; Christopher C Duke; Garrett W Gremel; Jacek Skarbinski
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

4.  Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014.

Authors:  John Weiser; John T Brooks; Jacek Skarbinski; Brady T West; Christopher C Duke; Garrett W Gremel; Linda Beer
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

5.  Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy.

Authors:  V E Stone; F F Mansourati; R M Poses; K H Mayer
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

6.  One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India.

Authors:  Amita Gupta; Dattaray G Saple; Girish Nadkarni; Bijal Shah; Satish Vaidya; Nitin Hingankar; Devidas Chaturbhuj; Praveen Deshmukh; Louise Walshe; Sarah E Hudelson; Maria James; Ramesh S Paranjape; Susan H Eshleman; Srikanth Tripathy
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.